Nibin Varghese

FDA investigator

Appears on 14 documents from 2021 to 2026, most often at sites in Illinois. Most often cites responsibilities of quality control unit (21 CFR 211.22).

14
Documents on file
6.9
Observations per 483
2021
First seen
2026
Most recent

What they cite most

From 96 observations

Activity by year

2021: 3, 2022: 1, 2023: 2, 2024: 4, 2025: 3, 2026: 1

Where

Illinois 5 · India 3 · Australia 1 · China 1 · Japan 1 · Ohio 1

Is Nibin Varghese coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

14 documents, newest first
FirmOpen
483 Aurobindo Pharma Limited, Unit VIIJan 28, 2026 · Polepally Jedcherla Mandal, Mahabubnagar, India
483 Sato Pharmaceutical Co., LtdNov 21, 2025 · Hachioji, Japan
483 Veganic SKN LimitedJul 21, 2025 · Rocklea, Australia
483 Concord Biotech Limited 1482-1486, Trasad RoadMay 2, 2025 · Dholka Ahmedabad, India
483 Hangzhou ApexTide Biomedical Technology Co., Ltd.Nov 1, 2024 · Hangzhou, China
483 TYCHE INDUSTRIES LIMITEDAug 16, 2024 · KAKINADA, India
483 FIRST PRIORITY INCORPORATEDJul 30, 2024 · Elgin, Illinois

About this profile

What does Nibin Varghese inspect?

Nibin Varghese appears on 14 documents on file covering 12 sites, most often in Illinois.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.67 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Nibin Varghese is dated Jan 28, 2026.